Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata.
about
Performance of CHROMAGAR candida and BIGGY agar for identification of yeast speciesPresumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida.Biofilm formation by Candida albicans isolated from intrauterine devicesCharacterization of a new clinical yeast species, Candida tunisiensis sp. nov., isolated from a strain collection from Tunisian hospitals.The ins and outs of DNA fingerprinting the infectious fungiIdentification, typing, antifungal resistance profile, and biofilm formation of Candida albicans isolates from Lebanese hospital patients.Candida infections of the genitourinary tract.Molecular analysis of microbial communities in endotracheal tube biofilms.Evaluation of a reformulated CHROMagar Candida.High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance.New chromogenic agar medium for the identification of Candida spp.Supplementation of CHROMagar Candida medium with Pal's medium for rapid identification of Candida dubliniensis.Canadian clinical practice guidelines for invasive candidiasis in adults.Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settingsEvaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida speciesCan the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar?Isolation, identification, and carriage of candidal species in PHLAs and their correlation with immunological status in cases with and without HAART.Rapid identification of yeast isolates from clinical specimens in critically ill trauma ICU patientsIn vitro interactions between tacrolimus and azoles against Candida albicans determined by different methodsSimple method for detecting fluconazole-resistant yeasts with chromogenic agar.Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.Production of white colonies on CHROMagar Candida medium by members of the Candida glabrata clade and other species with overlapping phenotypic traitsUse of CHROMagar Candida for genital specimens in the diagnostic laboratory.Advances in Candida detection platforms for clinical and point-of-care applicationsSimple, reliable, and cost-effective yeast identification scheme for the clinical laboratoryMembrane filtration test for rapid presumptive differentiation of four Candida species.Cost-effective and rapid presumptive identification of gram-negative bacilli in routine urine, pus, and stool cultures: evaluation of the use of CHROMagar orientation medium in conjunction with simple biochemical tests.Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species.Performance of candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida.Chromogenic tube test for presumptive identification or confirmation of isolates as Candida albicans.Persistence of pigment production by yeast isolates grown on CHROMagar Candida medium.Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida.Evaluation of CHROMagar Candida platesEvaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies.Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates.Evaluation of BBL CHROMagar orientation medium for detection and presumptive identification of urinary tract pathogens.Evaluation of chromogenic media and seminested PCR in the identification of Candida species.Candida tropicalis as a Predominant Isolate from Clinical Specimens and its Antifungal Susceptibility Pattern in a Tertiary Care Hospital in Southern India.Identifying Candida and other yeast-like fungi: utility of an identification algorithm in resource limited setting.In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
P2860
Q24797201-21B5B475-7C95-4CC8-863F-A7CB378E71FEQ25257510-0A0706AB-5BB7-4C90-9925-BA2755F7D089Q28716567-A25F7A6B-32A1-4748-AD0B-163124E0B150Q30573841-D82C5D6B-DF36-4A2E-94B7-A0B394D37E36Q33555593-E1C26462-C442-4A3B-B270-945F578B3800Q33759293-71014B4F-404D-42BF-A5BA-5D5597716110Q33825621-9D9D04B8-193F-452A-AA46-64141D1CC3EFQ33851592-04958E7B-ED30-44D6-8F4B-B1AF0D8E6046Q33972400-80FFECD8-AF9F-41E3-81A2-6F14B769F12FQ33976637-D5DA366F-5ACC-48C5-ADE7-CCDA6B8C84BFQ34102008-022AFDB7-0CED-41B8-8DA3-A082F728FA35Q34143717-4BBBB59E-EC39-4D74-9EB2-E58C026F27B0Q34237335-D296252C-2D6F-4BEC-BF16-24DCC51815EEQ34764156-06BC3956-D19F-4B25-8A68-77BCB3948AC8Q35073427-077798D6-2505-40E6-A689-2AE43503576BQ35614642-728CCC25-C36F-4EB7-863C-2723861E4E35Q35829592-0A056BFA-91D4-4272-899C-3DBCC8D6D5E6Q36182009-541C3585-6627-44DF-BAC9-70F752C337F8Q36425093-6DDCEB85-7671-48AB-B3E9-6172E784CE0CQ36535673-E5CCC26A-73AF-403B-9C9F-D14C6AF8A193Q36542312-F239B389-08FD-4357-BFFD-350960556C13Q36933401-801CF043-D025-4050-A7F5-C3B89FDBAA06Q37209669-6CA37FE3-DC88-4674-A385-46D059D93543Q37372500-B772D79C-C6D7-46FC-8F88-BA003D718F71Q39446355-76DE1C3C-D8D0-46EC-A59E-958962FF05D5Q39448823-5AA13A71-FFE3-44EF-8F62-A2DA4A11BAE4Q39462602-5A1CD6CB-33A4-4C5C-A8FC-3D35506E2EB6Q39464356-7D8AF6A8-AE3B-4BD9-8D77-3C6567F1445FQ39466704-BAC489F8-59C7-466F-ACDB-48F418B2779BQ39553170-A5157D60-8738-4705-9768-887892D34735Q39750930-CA4C1553-2B72-4A11-AAB5-FCA127DDAF2DQ39758166-792CCFAB-85C8-43ED-ABB0-D0E08BAC13F4Q40011397-3CCFD252-715F-4B80-8BF1-80428780748FQ40013370-E71CFB66-9873-4029-AC08-3992AF195C75Q40014176-05861019-6BAA-4096-BDE0-8C4F8791378CQ40014751-02CFDDA6-784A-4B35-A8FF-7562A6468ACFQ40760976-AE77E258-BB85-467B-B9DD-07AC2ACE39AFQ40988156-AAD3030E-196B-44C2-B34B-A507803E7161Q41501941-B4341A38-5271-491D-9C28-D401D294FC09Q41834480-A26F544B-808B-4150-AC4C-AE54C059760F
P2860
Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Application of CHROMagar Candi ...... Candida (Torulopsis) glabrata.
@ast
Application of CHROMagar Candi ...... Candida (Torulopsis) glabrata.
@en
type
label
Application of CHROMagar Candi ...... Candida (Torulopsis) glabrata.
@ast
Application of CHROMagar Candi ...... Candida (Torulopsis) glabrata.
@en
prefLabel
Application of CHROMagar Candi ...... Candida (Torulopsis) glabrata.
@ast
Application of CHROMagar Candi ...... Candida (Torulopsis) glabrata.
@en
P2093
P2860
P1476
Application of CHROMagar Candi ...... Candida (Torulopsis) glabrata
@en
P2093
P2860
P407
P577
1996-01-01T00:00:00Z